Top Rated Report: Acute Lung Injury - Pipeline Review, H2 2013 : Now at Market-Research-Reports.biz
Posted by Unknown on 3:05 AM with No comments
Global Markets Directs, 'Acute Lung Injury Pipeline Review, H2 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for
Acute Lung Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Lung Injury. Acute Lung Injury Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Reasons to buy
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Acute Lung Injury Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for Acute Lung Injury 10
Acute Lung Injury Therapeutics under Development by Companies 12
Acute Lung Injury Therapeutics under Investigation by Universities/Institutes 14
Late Stage Products 16
Comparative Analysis 16
Mid Clinical Stage Products 17
Comparative Analysis 17
Early Clinical Stage Products 18
Comparative Analysis 18
Discovery and Pre-Clinical Stage Products 19
Comparative Analysis 19
Acute Lung Injury Therapeutics - Products under Development by Companies 20
Acute Lung Injury Therapeutics - Products under Investigation by Universities/Institutes 21
Appendix
Methodology 98
Coverage 98
Secondary Research 98
Primary Research 98
Expert Panel Validation 98
Contact Us 99
Disclaimer 99
Number of Products Under Development for Acute Lung Injury, H2 2013 10
Products under Development for Acute Lung Injury - Comparative Analysis, H2 2013 11
Number of Products under Development by Companies, H2 2013 13
Number of Products under Investigation by Universities/Institutes, H2 2013 15
Comparative Analysis by Late Stage Development, H2 2013 16
Comparative Analysis by Mid Clinical Stage Development, H2 2013 17
Comparative Analysis by Early Clinical Stage Development, H2 2013 18
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2013 19
About Us
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact :
M/S SHEELA
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
Acute Lung Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Lung Injury. Acute Lung Injury Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Acute Lung Injury.
- A review of the Acute Lung Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Acute Lung Injury pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Acute Lung Injury.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Acute Lung Injury pipeline depth and focus of Indication therapeutics.
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Acute Lung Injury Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for Acute Lung Injury 10
Acute Lung Injury Therapeutics under Development by Companies 12
Acute Lung Injury Therapeutics under Investigation by Universities/Institutes 14
Late Stage Products 16
Comparative Analysis 16
Mid Clinical Stage Products 17
Comparative Analysis 17
Early Clinical Stage Products 18
Comparative Analysis 18
Discovery and Pre-Clinical Stage Products 19
Comparative Analysis 19
Acute Lung Injury Therapeutics - Products under Development by Companies 20
Acute Lung Injury Therapeutics - Products under Investigation by Universities/Institutes 21
Appendix
Methodology 98
Coverage 98
Secondary Research 98
Primary Research 98
Expert Panel Validation 98
Contact Us 99
Disclaimer 99
Number of Products Under Development for Acute Lung Injury, H2 2013 10
Products under Development for Acute Lung Injury - Comparative Analysis, H2 2013 11
Number of Products under Development by Companies, H2 2013 13
Number of Products under Investigation by Universities/Institutes, H2 2013 15
Comparative Analysis by Late Stage Development, H2 2013 16
Comparative Analysis by Mid Clinical Stage Development, H2 2013 17
Comparative Analysis by Early Clinical Stage Development, H2 2013 18
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2013 19
About Us
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact :
M/S SHEELA
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
Categories: Acute-Lung-Injury, Market-Research-reports
0 comments:
Post a Comment